CIRSE European Trainee Forum

However, the strongest predictor of LTP remains the minimal ablative margin (MAM), while MRI serves as a valuable complementary tool within a multimodal approach to optimize outcomes. Read more: lnkd.in/dtEW74wv 2/2

❓ Can pre-ablation MRI help predict local tumor progression (LTP) after CRLM ablation? Pre-ablation #MRI may support risk stratification for local tumor progression (LTP) by providing imaging features that can inform patient selection and treatment planning. 1/2

Join us on April 28th for the first-ever ECIO Women in IR Networking Breakfast hosted by Executive Committee members Laura Crocetti and Alex Barnacle. 🥞🥯 Kindly supported by Boston Scientific #WomeninIR #IO #InterventionalOncology

All-Access Pass holders now save 50%!🥳 To claim the discount, enter the code APP26ECIO when selecting the "Onsite Attendance for All-Access Pass holders" fee during registration. See you at #ECIO2026! 👉 Register now: t.ly/jUPHX #InterventionalOncology

#ClinicalCase courtesy of Dr. Gábor Mohos, Semmelweis University Budapest 🇭🇺 #CIRSE_ETF #IRTrainees #IRinlivertumors #IRad

IR offers a straightforward approach in many cases🧬 We present you a case of a 63yo male with a small solitary CRLM which was treated with US-guided microwave ablation. Both control CT and the follow-up CT confirmed adequate lesion coverage and appropriate safety margins.

⚕️ Directed at trainees and young staff members, the IO Foundation Course will enable you to get a first overview of the most important IO procedures and how they fit into a truly multidisciplinary approach to cancer care. ➡️ Learn more: bit.ly/4dIYijd

⚕️ The IO Foundation course provides young interventionists interested in expanding their practice to include oncology treatments a first introduction to the various fields involved in cancer care. Learn more and register for #ECIO2026 at ecio.org.

📚 The article “Optimizing Safety in Portal Vein Embolization: Puncture Technique and Tract Embolization”, recently published in @CVIR_Journal, focuses on procedural strategies that can help reduce complications and optimize outcomes during #PVE. ➡️ link.springer.com/article/10.100…

📚 We are pleased to highlight the article “Path forward: Cryoablation for colorectal liver metastases”, which explores the evolving role of cryoablation as a treatment option for patients with colorectal liver metastases (CRLM). 🔗 ejradiology.com/article/S0720-…

Thank you for your support! 😊 ETF's #LinkedIn page has just reached 3000 followers! linkedin.com/company/europe…

Register for CIRSE 2026 today and benefit from highly discounted rates:​ bit.ly/4iXh99w

Get hands-on experience with the latest tools and devices during the hands-on training sessions at #CIRSE2026! 📎💉

Happy Friday! 💥 Celebrate the weekend by watching this interesting lecture from #CIRSE2025 about uterine artery embolization as treatment for significant anemia in women with fibroids. ➡️ library.cirse.org/cirse2025/crs/…

Join us! bit.ly/4sb9BEx

🕕 Join us tonight from 18:00 CET! We will discuss the #IO essential and present the basic principles in #RFA, #MWA, and #cryoablation.

We are delighted to announce the speakers for the upcoming #ETFwebinar🎉 Speakers: Dr Ettore di Gaeta 🇮🇹 Dr Tina Berglyd Moshtagh-Holme 🇳🇴 Dr Lars Egil Roberg 🇳🇴 Dr Colm O'Sullivan 🇮🇪 Moderation: Dr. Charlotte Wintergerst 🇩🇪 ➡️ Register here: bit.ly/4sb9BEx

📚 CIRSE's patient information leaflet for uterine artery embolization is designed to inform patients about what they can expect to experience before, during, and after the procedure. ➡️ Learn more: cirse.org/wp-content/upl…

📚 Uterine artery embolisation (#UAE) is a minimally invasive treatment option for women with symptomatic fibroids. Check out the CIRSE standards of practice guidelines on UAE for symptomatic leiomyomata to learn more: link.springer.com/article/10.100…

Don't miss the upcoming #ETFwebinar! ➡️ Register for free: bit.ly/4sb9BEx